Insider record · § Dir,
10% Ra Capital Management, L.P. insider buys
Every disclosed SEC Form 4 open-market purchase by 10% Ra Capital Management, L.P. (Dir, · ARTV, PBLS), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.
Disclosed buys
10
Total bought
$448.3M
Avg Δ7d
+8.0%
Win rate · 7d
90%
Avg Δ30d
+15.9%
Last filing
2026-07-31
Buy history
| Filed | Ticker | Company | Value | Price @ | Δ1d | Δ7d | Δ30d |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | ARTV | Artiva Biotherapeutics, Inc. | $456K | $10.43 | +3.2% | +8.1% | — |
| 2026-07-28 | ARTV | Artiva Biotherapeutics, Inc. | $413K | $10.53 | −4.8% | +5.1% | — |
| 2026-07-23 | ARTV | Artiva Biotherapeutics, Inc. | $2.6M | $10.13 | −1.0% | +3.0% | +13.7% |
| 2026-07-22 | PBLS | Parabilis Medicines, Inc. | $6.9M | $30.81 | +6.5% | +3.1% | +27.8% |
| 2026-07-20 | ARTV | Artiva Biotherapeutics, Inc. | $1.4M | $9.15 | +9.3% | +12.8% | +27.9% |
| 2026-07-14 | ARTV | Artiva Biotherapeutics, Inc. | $194K | $9.35 | +6.1% | +7.0% | +20.9% |
| 2026-06-29 | ARTV | Artiva Biotherapeutics, Inc. | $292K | $9.62 | +0.8% | −1.9% | +4.2% |
| 2026-06-16 | ARTV | Artiva Biotherapeutics, Inc. | $4.6M | $8.91 | +11.6% | +10.0% | +1.5% |
| 2026-06-15 | PBLS | Parabilis Medicines, Inc. | $423.8M | $25.01 | +6.3% | +10.1% | +19.6% |
| 2026-06-11 | ARTV | Artiva Biotherapeutics, Inc. | $7.7M | $8.00 | +6.7% | +22.8% | +11.6% |